Toma Keser1, Ivan Gornik2, Frano Vučković3, Najda Selak1, Tamara Pavić1, Edita Lukić2, Ivan Gudelj3, Hrvoje Gašparović4, Bojan Biočina4, Therese Tilin5, Annika Wennerström6, Satu Männistö6, Veikko Salomaa6, Aki Havulinna6, Wei Wang7,8, James F Wilson9, Nish Chaturvedi5, Markus Perola6, Harry Campbell9, Gordan Lauc1,3, Olga Gornik10. 1. University of Zagreb Faculty of Pharmacy and Biochemistry, Ante Kovačića 1, 10 000, Zagreb, Croatia. 2. Clinical Hospital Centre Zagreb, Zagreb, Croatia. 3. Genos Glycoscience Research Laboratory, Zagreb, Croatia. 4. Department of Cardiac Surgery, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia. 5. Institute of Cardiovascular Science, University College London, London, UK. 6. National Institute for Health and Welfare (THL), Helsinki, Finland. 7. School of Medical and Health Sciences, Edith Cowan University, Perth, Australia. 8. Beijing Municipal Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China. 9. Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK. 10. University of Zagreb Faculty of Pharmacy and Biochemistry, Ante Kovačića 1, 10 000, Zagreb, Croatia. ogornik@pharma.hr.
Abstract
AIMS/HYPOTHESIS: Better understanding of type 2 diabetes and its prevention is a pressing need. Changes in human plasma N-glycome are associated with many diseases and represent promising diagnostic and prognostic biomarkers. Variations in glucose metabolism directly affect glycosylation through the hexosamine pathway but studies of plasma glycome in type 2 diabetes are scarce. The aim of this study was to determine whether plasma protein N-glycome is changed in individuals who are at greater risk of developing type 2 diabetes. METHODS: Using a chromatographic approach, we analysed N-linked glycans from plasma proteins in two populations comprising individuals with registered hyperglycaemia during critical illness (increased risk for development of type 2 diabetes) and individuals who stayed normoglycaemic during the same condition: AcuteInflammation (59 cases vs 49 controls) and AcuteInflammation Replication (52 cases vs 14 controls) populations. N-glycome was also studied in individuals from FinRisk (37 incident cases of type 2 diabetes collected at baseline vs 37 controls), Orkney Complex Disease Study (ORCADES; 94 individuals with HbA1c > 6.5% [47.5 mmol/mol] vs 658 controls) and Southall and Brent Revisited (SABRE) cohort studies (307 individuals with HbA1c > 6.5% [47.5 mmol/mol] vs 307 controls). RESULTS: Individuals with increased risk for diabetes type 2 development (AcuteInflammation and AcuteInflammation Replication populations), incident cases of type 2 diabetes collected at baseline (FinRisk population) and individuals with elevated HbA1c (ORCADES and SABRE populations) all presented with increased branching, galactosylation and sialylation of plasma protein N-glycans and these changes were of similar magnitude. CONCLUSIONS/ INTERPRETATION: Increased complexity of plasma N-glycan structures is associated with higher risk of developing type 2 diabetes and poorer regulation of blood glucose levels. Although further research is needed, this finding could offer a potential new approach for improvement in prevention of diabetes and its complications.
AIMS/HYPOTHESIS: Better understanding of type 2 diabetes and its prevention is a pressing need. Changes in human plasma N-glycome are associated with many diseases and represent promising diagnostic and prognostic biomarkers. Variations in glucose metabolism directly affect glycosylation through the hexosamine pathway but studies of plasma glycome in type 2 diabetes are scarce. The aim of this study was to determine whether plasma protein N-glycome is changed in individuals who are at greater risk of developing type 2 diabetes. METHODS: Using a chromatographic approach, we analysed N-linked glycans from plasma proteins in two populations comprising individuals with registered hyperglycaemia during critical illness (increased risk for development of type 2 diabetes) and individuals who stayed normoglycaemic during the same condition: AcuteInflammation (59 cases vs 49 controls) and AcuteInflammation Replication (52 cases vs 14 controls) populations. N-glycome was also studied in individuals from FinRisk (37 incident cases of type 2 diabetes collected at baseline vs 37 controls), Orkney Complex Disease Study (ORCADES; 94 individuals with HbA1c > 6.5% [47.5 mmol/mol] vs 658 controls) and Southall and Brent Revisited (SABRE) cohort studies (307 individuals with HbA1c > 6.5% [47.5 mmol/mol] vs 307 controls). RESULTS: Individuals with increased risk for diabetes type 2 development (AcuteInflammation and AcuteInflammation Replication populations), incident cases of type 2 diabetes collected at baseline (FinRisk population) and individuals with elevated HbA1c (ORCADES and SABRE populations) all presented with increased branching, galactosylation and sialylation of plasma protein N-glycans and these changes were of similar magnitude. CONCLUSIONS/ INTERPRETATION: Increased complexity of plasma N-glycan structures is associated with higher risk of developing type 2 diabetes and poorer regulation of blood glucose levels. Although further research is needed, this finding could offer a potential new approach for improvement in prevention of diabetes and its complications.
Authors: Akintunde O Akinkuolie; Aruna D Pradhan; Julie E Buring; Paul M Ridker; Samia Mora Journal: Arterioscler Thromb Vasc Biol Date: 2015-04-23 Impact factor: 8.311
Authors: James D Otvos; Irina Shalaurova; Justyna Wolak-Dinsmore; Margery A Connelly; Rachel H Mackey; James H Stein; Russell P Tracy Journal: Clin Chem Date: 2015-03-16 Impact factor: 8.327
Authors: Anita Johswich; Christine Longuet; Judy Pawling; Anas Abdel Rahman; Michael Ryczko; Daniel J Drucker; James W Dennis Journal: J Biol Chem Date: 2014-04-17 Impact factor: 5.157
Authors: Douglas M Oswald; Sylvain D Lehoux; Julie Y Zhou; Leandre M Glendenning; Richard D Cummings; Brian A Cobb Journal: Glycobiology Date: 2022-08-18 Impact factor: 5.954
Authors: Leila B Giron; Clovis S Palmer; Qin Liu; Xiangfan Yin; Emmanouil Papasavvas; Radwa Sharaf; Behzad Etemad; Mohammad Damra; Aaron R Goldman; Hsin-Yao Tang; Rowena Johnston; Karam Mounzer; Jay R Kostman; Pablo Tebas; Alan Landay; Luis J Montaner; Jeffrey M Jacobson; Jonathan Z Li; Mohamed Abdel-Mohsen Journal: Nat Commun Date: 2021-06-29 Impact factor: 17.694